Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition

Background: Renal cell carcinoma (RCC) accounts for around 85% of all primary kidney neoplasms, which is one of top 10 common cancers worldwide. Nuclear receptor suppressor of variegation, enhancer of zeste, and trithorax (SET) domain-containing 2 (NSD2), belonging to NSD protein family, functions a...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xu, Piao, Lianhua, Yuan, Xiaofeng, Wang, Luhui, Liu, Zhiwei, He, Xiaozhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818196/
https://www.ncbi.nlm.nih.gov/pubmed/31692936
http://dx.doi.org/10.7150/ijms.36128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818196/
https://www.ncbi.nlm.nih.gov/pubmed/31692936
http://dx.doi.org/10.7150/ijms.36128

Ejemplares similares